Noting the high incidence of childhood pneumonia in many parts of the world, the inclusion of oxygen saturation (SpO2) and respiratory rate measurement in pneumonia screening guidelines, and the ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse ...

Irvine, CA-based Masimo Corporation MASI recently announced the 510(k) clearance and full-market release of its proprietary Rad-97 Pulse CO-Oximeter. The launch of Rad-97 offers Masimo noninvasive and ...

NEUCHATEL, Switzerland-- (BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the CE marking of the Rad-97 ™ Pulse CO-Oximeter ®. Rad-97 offers the same Measure-through Motion and Low Perfusion™ ...

The new Universal ReSposable pulse oximetry sensor was created after more than 10 years of research and development with feedback from hundreds of clinicians on what they wanted most in a sensor – ...

Masimo Corporation MASI received FDA approval for the domestic use of Rad-97 Pulse CO-Oximeter. This product will offer non-invasive and continuous monitoring. The product comprises Measure-through ...

Masimo, a global medical technology company, announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp on ...

Masimo (NASDAQ: MASI) announced today the CE marking of the Rad-97 ™ Pulse CO-Oximeter ®. Rad-97 offers the same Measure-through Motion and Low Perfusion™ SET ® pulse oximetry and upgradeable rainbow ...

“Multiple studies have shown that Masimo SET ® pulse oximetry can help improve CCHD screening, helping to save many newborns’ lives while reducing the cost of care,” commented Joe Kiani, Founder and ...

Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse CO-Oximeter ®. Eve combines the power of ...